English | Español

Regulatory
+ Regulatory
Robert Hadley | Jul 5, 2017

European regulators consider expanding use of Amgen parathyroid drug to young patients
+ Regulatory
Michael McGrady | Jul 5, 2017

Policy experts weigh in on new executive order on drug pricing
+ Regulatory
Erianne Leatherman | Jul 2, 2017

Pfizer’s cardiomyopathy drug, tafamidis, on FDA fast track
+ Regulatory
Nicholas Gueguen | Jul 1, 2017

FDA OKs Kevzara for moderate to severe rheumatoid arthritis
+ Regulatory
Nicholas Gueguen | Jul 1, 2017

European School of Oncology, Pfizer create initiative to help prolong lives of those with breast cancer
+ Regulatory
Nicholas Gueguen | Jun 30, 2017

FDA gives go-ahead to use Keytruda to treat certain solid tumor cancer cases
+ Regulatory
Nicholas Gueguen | Jun 30, 2017

ALS Association adds its voice against budget plan to cut funds for National ALS Registry
+ Regulatory
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes